By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CHDI, Inc. 

350 Seventh Avenue, Suite 601

New York  New York  10001  U.S.A.
Phone: 212-239-9300 Fax: 212-239-2101


Company News
Alnylam Pharmaceuticals (ALNY), Medtronic, Inc. (MDT) & CHDI, Inc. Form RNAi Delivery Collaboration 11/8/2010 8:08:01 AM
Albany Molecular Research, Inc. (AMRI) Commences Drug Discovery Collaboration with CHDI, Inc. 4/29/2009 9:28:10 AM
Stem Cell Sciences plc (STEM.L) Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 11/10/2008 9:20:43 AM
Galapagos NV and CHDI, Inc. Enter New Collaboration Agreements 10/29/2008 9:41:02 AM
Vertex Pharmaceuticals Incorporated (VRTX) Establishes Early-Stage Huntington’s Disease Research Collaboration with CHDI, Inc. 6/17/2008 10:56:06 AM
Huntington Disease Foundation to Assess Six of CHDI, Inc.'s Drugs for Potential to Delay or Slow Progression of the Disease 1/24/2008 9:54:18 AM
Serenex and CHDI, Inc. Form Agreement to Evaluate Proprietary Small Molecule Hsp90 Inhibitors as a Potential Treatment for Huntington's Disease 1/17/2008 9:24:08 AM
CHDI, Inc. Selects Evotec As Strategic Drug Discovery Partner In The Search For Huntington Disease Treatments 8/10/2006 1:17:01 PM
CHDI, Inc. And Edison Pharmaceuticals, Inc. Enter Collaborative Agreement; Development Of Therapeutics Targeting Huntington's Disease 8/1/2006 12:47:28 PM
Cellumen, Inc. And CHDI, Inc. Announce An Agreement To Create A Systems Cell Biology Profile Of Huntington's Disease 2/23/2006 2:48:08 PM